Steven K. Libutti, MD, FACS
Senior Vice President of Oncology Services for RWJBarnabas Health
Steven K. Libutti, MD, FACS was appointed as Director of
Rutgers Cancer Institute of New Jersey and Vice Chancellor for Cancer Programs, Rutgers Biomedical and Health
Sciences in January 2017. In addition to his leadership roles within Rutgers
University, Dr. Libutti also serves as Senior Vice President of Oncology
Services for RWJBarnabas Health, further strengthening the university’s
partnership with the healthcare system. He is also a Professor of Surgery
at Rutgers Robert Wood Johnson Medical School.
Most recently, Dr. Libutti served as Director for the Montefiore Einstein
Center for Cancer Care in New York City and was a Professor and Vice Chairman
of the Department of Surgery and Professor in the Department of Genetics
at Albert Einstein College of Medicine and Montefiore Health System. A
surgical oncologist, Dr. Libutti is an internationally known expert in
endocrine surgery and the management of neuroendocrine tumors. He is the
immediate Past President of the American Association of Endocrine Surgeons.
His clinical practice focuses on gastrointestinal malignancies including
cancers of the liver and pancreas.
The recipient of funding from the National Cancer Institute (NCI) for the
past 20 years, Dr. Libutti is also a researcher whose work focuses on
developing novel cancer therapies through an understanding of the tumor
microenvironment and blood vessel formation in tumors. He is studying
tumor neovascular formation and the interaction between tumor cells, endothelial
cells and the components of the tumor microenvironment including fibroblasts
and cancer stem cells. His work also focuses on a better understanding
of the tumor suppressor genes MEN1 and FILIP1L.
After graduating magna cum laude from Harvard College, Dr. Libutti received
his medical degree from the College of Physicians and Surgeons of Columbia
University. He remained at Presbyterian Hospital in New York where he
completed his residency in surgery, followed by a fellowship at the NCI
in surgical oncology and endocrine surgery. He continued at the NCI where
he became a tenured Senior Investigator and Chief of the Tumor Angiogenesis
Section in the Surgery Branch. He has published over 280 peer reviewed
journal articles, is Editor-in-Chief of the Nature Journal Cancer Gene
Therapy, and holds seven U.S. patents.